400
Participants
Start Date
Not specified
Study Completion Date
September 30, 1996
Zidovudine
Metropolitan Hosp Ctr, New York
Mount Sinai Med Ctr / Pediatrics, New York
Harlem Hosp Ctr, New York
Lincoln Hosp Ctr, The Bronx
Bronx Lebanon Hosp Ctr, The Bronx
Albert Einstein College of Medicine, The Bronx
Westchester Hosp, Valhalla
North Shore Univ Hosp, Great Neck
King's County Hosp Ctr / Pediatrics, Brooklyn
Children's Hosp at Albany Med Ctr, Albany
Children's Hosp Pact Prog / Children's Hosp of Buffalo, Buffalo
Univ of Rochester Medical Center, Rochester
Georgetown Univ Med Ctr, Washington D.C.
Howard Univ Hosp, Washington D.C.
Univ of Maryland at Baltimore / Univ Med Ctr, Baltimore
Univ of Miami (Pediatric), Miami
Univ of Alabama at Birmingham Schl of Med / Pediatrics, Birmingham
Cook County Hosp, Chicago
Univ of Illinois College of Medicine / Pediatrics, Chicago
Children's Med Ctr of Dallas, Dallas
San Francisco Gen Hosp, San Francisco
Children's Hosp of Washington DC, Washington D.C.
Duke Univ Med Ctr, Durham
Med Univ of South Carolina, Charleston
Saint Jude Children's Research Hosp of Memphis, Memphis
Columbus Children's Hosp, Columbus
Chicago Children's Memorial Hosp, Chicago
Univ of Chicago Children's Hosp, Chicago
Tulane Univ / Charity Hosp of New Orleans, New Orleans
Children's Hosp of Denver, Denver
UCLA Med Ctr / Pediatric, Los Angeles
Kaiser Permanente / UCLA Med Ctr, Downey
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles
UCSF / Moffitt Hosp - Pediatric, San Francisco
Univ of Connecticut / Farmington, Farmington
Yale Univ Med School, New Haven
Children's Hosp of Boston, Boston
Baystate Med Ctr of Springfield, Springfield
Univ of Massachusetts Med School, Worcester
Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark
Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl, Newark
San Juan City Hosp, San Juan
Collaborators (1)
Glaxo Wellcome
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH